Jim Simons Aerie Pharmaceuticals Inc Transaction History

Renaissance Technologies LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$6.37 - $15.23 $1.31 Million - $3.12 Million	205,163 Added 34.76%	795,473 $12 Million
Q2 2022 Aug 12, 2022	BUY	$4.95 - $9.16 $455,895 - $843,636	92,100 Added 18.49%	590,310 $4.43 Million
Q1 2022 May 13, 2022	BUY	$5.64 - $9.8 $642,396 - $1.12 Million	113,900 Added 29.64%	498,210 $4.53 Million
Q4 2021 Feb 11, 2022	BUY	$7.02 - $13.33 $439,452 - $834,458	62,600 Added 19.46%	384,310 $2.7 Million
Q3 2021 Nov 12, 2021	SELL	$11.32 - $16.63 $516,905 - $759,375	-45,663 Reduced 12.43%	321,710 $3.67 Million
Q2 2021 Aug 13, 2021	BUY	$15.16 - $18.97 $2.12 Million - $2.65 Million	139,863 Added 61.48%	367,373 $5.88 Million
Q1 2021 May 13, 2021	SELL	$13.12 - $20.9 $774,080 - $1.23 Million	-59,000 Reduced 20.59%	227,510 $4.07 Million
Q4 2020 Feb 10, 2021	SELL	$9.12 - $14.49 $297,220 - $472,229	-32,590 Reduced 10.21%	286,510 $3.87 Million
Q3 2020 Nov 13, 2020	BUY	$10.46 - $14.46 $346,226 - $478,626	33,100 Added 11.57%	319,100 $3.76 Million
Q2 2020 Aug 13, 2020	BUY	$12.0 - $16.13 $3.43 Million - $4.61 Million	286,000 New	286,000 $4.22 Million
Q1 2020 May 14, 2020	SELL	$11.84 - $25.52 $1.66 Million - $3.59 Million	-140,600 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$17.72 - $25.1 $985,231 - $1.4 Million	55,600 Added 65.41%	140,600 $3.4 Million
Q3 2019 Nov 13, 2019	BUY	$18.41 - $28.0 $1.56 Million - $2.38 Million	85,000 New	85,000 $1.63 Million

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.